| Joi A Ennis, NP | |
|
240 Williamson St Ste 305, Elizabeth, NJ 07202-3672 | |
| (908) 282-2000 | |
| Not Available |
| Full Name | Joi A Ennis |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Women's Health |
| Location | 240 Williamson St Ste 305, Elizabeth, New Jersey |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205341658 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LW0102X | Nurse Practitioner - Women's Health | 26NJ00679500 (New Jersey) | Primary |
| Entity Name | University Physician Associates Of New Jersey Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922018514 PECOS PAC ID: 9830003417 Enrollment ID: O20041026000021 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
| Entity Name | City Of Newark |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1356561278 PECOS PAC ID: 8123169182 Enrollment ID: O20100113000101 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
| Entity Name | Barnabas Health Medical Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841557246 PECOS PAC ID: 9537316955 Enrollment ID: O20120820000951 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
| Entity Name | Trinitas Physicians Practice Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205189941 PECOS PAC ID: 6709002850 Enrollment ID: O20140725000027 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
| Entity Name | Rwjbh Observation Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760095806 PECOS PAC ID: 5193137503 Enrollment ID: O20201209000008 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joi A Ennis, NP 240 Williamson St Ste 305, Elizabeth, NJ 07202-3672 Ph: (908) 282-2000 | Joi A Ennis, NP 240 Williamson St Ste 305, Elizabeth, NJ 07202-3672 Ph: (908) 282-2000 |
News Archive
It's March 24th again and the World Tuberculosis Day reminds us that for almost 50 years no new drugs have been developed against this terrible disease, which is currently killing nearly two million people worldwide each year. It's a global problem because the emergence of drug resistant strains of this infectious disease - normally associated with poverty - is a growing problem even in high-income economies.
In recognition of Red Ribbon Week, October 23-31, 2012, Gateway Foundation Alcohol & Drug Treatment is working to build awareness among communities regarding the dangerous health risks associated with synthetic drug use.
Millions of people are afflicted with inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and 30 percent of new cases occur in childhood. Mucin 1, an epithelial mucin that has been shown to elicit both an immune response and to have altered glycosylation in disease, may be a noninvasive indicator of the progression of these illnesses.
As the COVID-19 outbreak took hold in Italy, researchers working on a nuclear physics experiment called CUORE at an underground laboratory in central Italy scrambled to keep the ultrasensitive experiment running and launch new tools and rules for remote operations.
Mapi, the market leader in Prospective Real-World Evidence generation, Health Research Analytics and Evidence Synthesis announces their collaboration with Saama Technologies, Inc., the leading Big Data solutions company.
› Verified 6 days ago
Priscilla Maranon, ANP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 216 Palmer St, Elizabeth, NJ 07202 Phone: 908-352-2656 | |
Vijayeta Dripaul, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 32 Oakwood Pl, Elizabeth, NJ 07208 Phone: 908-208-9099 | |
Virginia Guanco-villanueva, A.P.N. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 240 Williamson St, Suite 403, Elizabeth, NJ 07202 Phone: 908-289-6996 | |
Novil Kaur, Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 240 Williamson St Ste 305, Elizabeth, NJ 07202 Phone: 908-354-5353 | |
Mirleivis D Sanchez Ruiz, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 935 Cross Ave, Elizabeth, NJ 07208 Phone: 551-556-8691 | |
Tony Malek, NP-C Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1150 Dickinson St, Elizabeth, NJ 07201 Phone: 201-522-4009 | |
Kacy Eunkyung In, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 817 Rahway Ave, Elizabeth, Elizabeth, NJ 07202 Phone: 908-353-5750 |